Article Sidebar

PDF
Issue: Vol. 57
Section: Research Article
DOI: 10.47972/vjcts.v57i.1927
Date Published: 29/10/2026
Views 5
Downloads 1
How to Cite
Nguyen, D. T., Nguyen, T. N. K., & Lam, T. C. (2026). Initial results of endovascular drug-eluting stent placement for the treatment of chronic lower extremity arterial disease at Thong Nhat Hospital. The Vietnam Journal of Cardiovascular and Thoracic Surgery, 57, 205-212. https://doi.org/10.47972/vjcts.v57i.1927

Initial results of endovascular drug-eluting stent placement for the treatment of chronic lower extremity arterial disease at Thong Nhat Hospital

Duy Tan Nguyen1,2, Tan Nguyen Khoi Nguyen, Thao Cuong Lam3,4,
1 Thong Nhat Hospital
2 Vietnam National University Ho Chi Minh City
3 University Medical Center Ho Chi Minh City
4 University of Medicine and Pharmacy at Ho Chi Minh City

Main Article Content

Abstract

Introduction: Chronic lower extremity arterial disease is increasingly common, particularly among elderly patients with multiple comorbidities. Drug-eluting stents have emerged as an effective endovascular option, offering improved patency and reduced restenosis. This study is to evaluate the initial outcomes of drug-eluting stent placement for chronic lower extremity arterial disease at Thong Nhat Hospital.


Patients and Methods: A retrospective case-series study was conducted on 35 patients with chronic lower extremity arterial disease who underwent endovascular drug-eluting stent placement between 1/2022 and 12/2024. Outcome measures included changes in Rutherford classification, ankle–brachial index (ABI), wound healing rate, vascular patency, and mortality. Clinical and imaging follow-up assessments were performed at 6, 12, and 24 months after the intervention.


Results: Significant improvement in clinical symptoms and ABI values was observed at follow-up (p < 0.001). Wound healing rates were 84.6% at 6 months and 100% at 24 months. Primary patency at 24 months was 88.6%.


Conclusions: Drug-eluting stent placement demonstrates favorable mid-term efficacy in improving limb perfusion and wound healing with an acceptable safety profile in patients with chronic lower extremity arterial disease.

Keywords

Chronic lower extremity arterial disease, drug-eluting stent, endovascular intervention, initial outcomes

Article Details

References

1. Song, P., et al., Global, regional, and national prevalence and risk factors for peripheral artery disease in 2015: an updated systematic review and analysis. Lancet Glob Health, 2019. 7(8): p. e1020-e1030.
2. Adam, D.J., et al., Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial. Lancet, 2005. 366(9501): p. 1925-34.
3. Aboyans, V., et al., 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteriesEndorsed by: the European Stroke Organization (ESO)The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS). Eur Heart J, 2018. 39(9): p. 763-816.
4. Bosiers, M., et al., ZILVERPASS Study: ZILVER PTX Stent vs. Bypass Surgery in Femoropopliteal Lesions, 3 year results and economic analysis. J Cardiovasc Surg (Torino), 2023. 64(4): p. 413-421.
5. Lâm, V.N. and H.T. Nguyễn, Đánh giá kết quả can thiệp nội mạch điều trị hẹp động mạch chậu đùi mạn tính có thiếu máu chi trầm trọng. Tạp chí Y học Việt Nam, 2023. 525(1B).
6. Abdullah, K., et al., Drug-Eluting Stents for Treatment of Peripheral Artery Disease. Am J Cardiovasc Drugs, 2018. 18(3): p. 175-180.
7. Kluckner, M., et al., Long-Term Results of Endovascular Treatment with Nitinol Stents for Femoropopliteal TASC II C and D Lesions. Medicina (Kaunas), 2022. 58(9).
8. Gouëffic, Y., et al., Efficacy of a Drug-Eluting Stent Versus Bare Metal Stents for Symptomatic Femoropopliteal Peripheral Artery Disease: Primary Results of the EMINENT Randomized Trial. Circulation, 2022. 146(21): p. 1564-1576.
9. Iida, O., et al., 24-Month Efficacy and Safety Results from Japanese Patients in the IMPERIAL Randomized Study of the Eluvia Drug-Eluting Stent and the Zilver PTX Drug-Coated Stent. Cardiovasc Intervent Radiol, 2021. 44(9): p. 1367-1374.
10. Darling, J.D., et al., Outcomes following drug-coated balloons and drug-eluting stents in patients with peripheral arterial disease. J Vasc Surg, 2025. 82(4): p. 1321-1331.e2.